[1] Ferrari Roberto,RAAS inhibition and mortality in hypertension.[J] .Glob Cardiol Sci Pract, 2013, 7(13): 269-78.
[2] G Arun Govind,Kamalanathan Agamudi Shivasankaran,Vijayalakshmi Mookambeswaran Arunachalam et al. Efficient purification of Apolipoprotein A1 (ApoA1) from plasma by HEA HyperCel?: An alternative approach.[J] .J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2018, 10(73): 104-109.
[3] Zhang Jing,Song Yanlin,Shan Baoyin et al. Elevated level of D-dimer increases the risk of stroke.[J] .Oncotarget, 2018, 9(15): 2208-2219.
[4] Pathak Abhishek,Kumar Pradeep,Pandit Awadh Kishor et al. Is Prevalence of Hypertension Increasing in First-Ever Stroke Patients?: A Hospital-Based Cross-Sectional Study.[J] .Ann Neurosci, 2018, 25(33): 219-222.
[5] Kim Tae-Hoon,Yang Pil-Sung,Yu Hee Tae et al. Effect of hypertension duration and blood pressure level on ischaemic stroke risk in atrial fibrillation: nationwide data covering the entire Korean population.[J] .Eur. Heart J., 2019, 40(24): 809-819.
[6] Kolaszko A, Kubiak G, Nowalanykozielska E .[Parathormone and vitamin d in heart failure - theoretical influence on disease development and potential therapy targets].[J]. Wiad Lek, 2017, 70(4):804-811.
[7] 梁黎,应可净,章锐锋.肾素血管紧张素系统与静脉血栓关系的研究进展[J].国际呼吸杂志,2011,31(18):1429-1431.
[8] Khaleghi M,Saleem U,McBane R D et al. African-American ethnicity is associated with higher plasma levels of D-dimer in adults with hypertension.[J] .J. Thromb. Haemost., 2009, 7(18): 34-40.
[9] 王陇德,刘建民,杨弋,彭斌,王伊龙.我国脑卒中防治仍面临巨大挑战——《中国脑卒中防治报告2018》概要[J].中国循环杂志,2019,34(2):105-119. |
